The results of current imaging studies in Wt1-Igf2 mice have confirmed the higher accuracy of T2-weighted MRI for early detection, delineation of margins, and for assessment of structural heterogeneity of Wilms tumors, as compared to T1-weghted MRI and CT with or without i.v. contrast enhancement. The gene discussed is WT1; the disease is Nephroblastoma.